Good assessment. PAA have a lot of things coming up in terms of grants, beginning of the trial and acceptance into the Healey platform. But the 2 I'm looking forward to in order of importance are .
- OLE quarterly updates, the next one may be a bit soon to see anything significant, but the 2nd quarter will be the one. If all 10 or a majority continue to be stable, it may be enough to trigger a deal or takeover.
- The pre clinical lab results for Parkinson's and Alzheimer's. The CEO has already advised BP have been consulted on what they would like to see. Having a second bite at the cherry on top of ALS/MND will add to Monepantels attractiveness.
But as you correctly point out the market can be unpredictable.
The market may also take a little while to become completely comfortable with the recent board renewal as well, if I was watching from a distance I would also be cautious.
Cheers
Good assessment. PAA have a lot of things coming up in terms of...
-
- There are more pages in this discussion • 205 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $99.65M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $95.38K | 475.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 135256 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 79851 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |